找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

新窗
投票 SCIE期刊JOURNAL OF LIPOSOME RESEARCH 2024/2025影响因子:3.652 (J LIPOSOME RES) (0898-2104). (PHARMACOLOGY & PHARMACY)(药理学与药学)S  ...234
Total Citations:1974; 2023 JIF:3.652; JIFRank: 94/354 ; Rank-JIF: 94; Number-of-JIF:354; 5 Year JIF:4.825; 5 Year JIF Quartile:Q1; JIF Without Self Cites:3.4; Immediacy Index:0.5; Immediacy Index-dealt:0.505; 2023 JCI:0.78; JCI Rank: 133/354 ; Total Articles:34; JCI Quartile:Q2; JCI Percentile:62.57; Eigenfactor:0.001; Normalized Eigenfactor:0.209; Article Influence Score:0.619; JIF Percentile:73.6; JIF Quartile:Q2; AIS Quartile:Q2; Citable Items:44; % of Articles in Citable items:0.7727; Cited Half-Life:6.8; Citing Half-Life:7.1; % of OA Gold:0.0495; Publisher name:GADJAH MADA UNIV, DEPT CHEMISTRY; Publisher address:JALAN PANCASILA, YOGYAKAR
投票 SCIE期刊International Journal of Clinical Pharmacy 2024/2025影响因子:2.689 (INT J CLIN PHARM-NET) (2210-7703). (PHARMACOLOGY  ...234
Total Citations:3941; 2023 JIF:2.689; JIFRank: 173/354 ; Rank-JIF: 173; Number-of-JIF:354; 5 Year JIF:2.491; 5 Year JIF Quartile:Q3; JIF Without Self Cites:2.3; Immediacy Index:0.7; Immediacy Index-dealt:0.791; 2023 JCI:0.58; JCI Rank: 207/354 ; Total Articles:94; JCI Quartile:Q3; JCI Percentile:41.67; Eigenfactor:0.004; Normalized Eigenfactor:0.889; Article Influence Score:0.583; JIF Percentile:51.3; JIF Quartile:Q2; AIS Quartile:Q3; Citable Items:125; % of Articles in Citable items:0.752; Cited Half-Life:5.6; Citing Half-Life:6.8; % of OA Gold:0.4062; Publisher name:EUROPEAN UNIV INST; Publisher address:COMMUNICATIONS SERV-PUBL UNIT, VILLA
投票 SCIE期刊Clinical Pharmacology in Drug Development 2024/2025影响因子:1.559 (CLIN PHARM DRUG DEV) (2160-7648). (PHARMACOLOGY &  ...234
Total Citations:1473; 2023 JIF:1.559; JIFRank: 265/354 ; Rank-JIF: 265; Number-of-JIF:354; 5 Year JIF:1.718; 5 Year JIF Quartile:Q3; JIF Without Self Cites:1.4; Immediacy Index:0.3; Immediacy Index-dealt:0.388; 2023 JCI:0.55; JCI Rank: 218/354 ; Total Articles:115; JCI Quartile:Q3; JCI Percentile:38.56; Eigenfactor:0.003; Normalized Eigenfactor:0.574; Article Influence Score:0.515; JIF Percentile:25.3; JIF Quartile:Q3; AIS Quartile:Q3; Citable Items:116; % of Articles in Citable items:0.9914; Cited Half-Life:3.9; Citing Half-Life:7.6; % of OA Gold:0.3497; Publisher name:MDPI; Publisher address:ST ALBAN-ANLAGE 66, BASEL, SWITZERLAND, CH-4052;
投票 SCIE期刊ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 2024/2025影响因子:4.115 (ANTIMICROB AGENTS CH) (0066-4804). (PHARMACOLOGY & PHA  ...234
Total Citations:63154; 2023 JIF:4.115; JIFRank: 78/354 ; Rank-JIF: 78; Number-of-JIF:354; 5 Year JIF:4.328; 5 Year JIF Quartile:Q1; JIF Without Self Cites:3.8; Immediacy Index:0.8; Immediacy Index-dealt:0.887; 2023 JCI:1.24; JCI Rank: 52/354 ; Total Articles:329; JCI Quartile:Q1; JCI Percentile:85.45; Eigenfactor:0.035; Normalized Eigenfactor:7.671; Article Influence Score:1.23; JIF Percentile:78.1; JIF Quartile:Q1; AIS Quartile:Q1; Citable Items:330; % of Articles in Citable items:0.997; Cited Half-Life:10.7; Citing Half-Life:6.9; % of OA Gold:0.2958; Publisher name:UNIV CHICAGO PRESS; Publisher address:1427 E 60TH ST, CHICAGO, USA, IL, 6063
投票 SCIE期刊International Journal for Parasitology-Drugs and Drug Resistance 2024/2025影响因子:4.165 (INT J PARASITOL-DRUG) (2211  ...234
Total Citations:1672; 2023 JIF:4.165; JIFRank: 78/354 ; Rank-JIF: 78; Number-of-JIF:354; 5 Year JIF:3.798; 5 Year JIF Quartile:Q2; JIF Without Self Cites:3.9; Immediacy Index:0.8; Immediacy Index-dealt:0.869; 2023 JCI:1.15; JCI Rank: 61/354 ; Total Articles:39; JCI Quartile:Q1; JCI Percentile:82.91; Eigenfactor:0.002; Normalized Eigenfactor:0.467; Article Influence Score:0.977; JIF Percentile:78.1; JIF Quartile:Q1; AIS Quartile:Q1; Citable Items:39; % of Articles in Citable items:1; Cited Half-Life:5; Citing Half-Life:9.7; % of OA Gold:0.9254; Publisher name:SISMEL EDIZIONI GALLUZZO; Publisher address:CASELLA POSTALE 90, TAVARNUZZE, Italy, 50
投票 SCIE期刊HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL 2024/2025影响因子:1.805 (HUM PSYCHOPHARM CLIN) (0885-6222). (PHARM  ...234
Total Citations:1866; 2023 JIF:1.805; JIFRank: 240/354 ; Rank-JIF: 240; Number-of-JIF:354; 5 Year JIF:1.728; 5 Year JIF Quartile:Q3; JIF Without Self Cites:1.8; Immediacy Index:0.2; Immediacy Index-dealt:0.223; 2023 JCI:0.5; JCI Rank: 236/354 ; Total Articles:16; JCI Quartile:Q3; JCI Percentile:33.47; Eigenfactor:0.001; Normalized Eigenfactor:0.154; Article Influence Score:0.488; JIF Percentile:32.3; JIF Quartile:Q3; AIS Quartile:Q3; Citable Items:22; % of Articles in Citable items:0.7273; Cited Half-Life:11.9; Citing Half-Life:8.8; % of OA Gold:0.2747; Publisher name:WARSAW SCH ECONOMICS; Publisher address:AL NIEPODLEGLOSCI 162, WARSAW, POLA
投票 SCIE期刊INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY 2024/2025影响因子:4.546 (INT J NEUROPSYCHOPH) (1461-1457). (PHARMACO  ...234
Total Citations:6971; 2023 JIF:4.546; JIFRank: 60/354 ; Rank-JIF: 60; Number-of-JIF:354; 5 Year JIF:4.744; 5 Year JIF Quartile:Q1; JIF Without Self Cites:4.5; Immediacy Index:0.6; Immediacy Index-dealt:0.639; 2023 JCI:1.15; JCI Rank: 61/354 ; Total Articles:50; JCI Quartile:Q2; JCI Percentile:75; Eigenfactor:0.006; Normalized Eigenfactor:1.225; Article Influence Score:1.48; JIF Percentile:77.6; JIF Quartile:Q1; AIS Quartile:Q2; Citable Items:56; % of Articles in Citable items:0.8929; Cited Half-Life:8.5; Citing Half-Life:8.6; % of OA Gold:0.9091; Publisher name:UNIV CALIFORNIA PRESS, JOURNALS DIV; Publisher address:155 GRAND AVENUE, STE 400,
投票 SCIE期刊JOURNAL OF MICROENCAPSULATION 2024/2025影响因子:3.140 (J MICROENCAPSUL) (0265-2048). (PHARMACOLOGY & PHARMACY)(药理学与药学  ...234
Total Citations:3255; 2023 JIF:3.140; JIFRank: 136/354 ; Rank-JIF: 136; Number-of-JIF:354; 5 Year JIF:4.295; 5 Year JIF Quartile:Q1; JIF Without Self Cites:3; Immediacy Index:0.6; Immediacy Index-dealt:0.676; 2023 JCI:0.68; JCI Rank: 168/354 ; Total Articles:44; JCI Quartile:Q2; JCI Percentile:70.47; Eigenfactor:0.001; Normalized Eigenfactor:0.213; Article Influence Score:0.522; JIF Percentile:56.8; JIF Quartile:Q2; AIS Quartile:Q2; Citable Items:47; % of Articles in Citable items:0.9362; Cited Half-Life:9.6; Citing Half-Life:6.5; % of OA Gold:0.0077; Publisher name:TAYLOR & FRANCIS LTD; Publisher address:2-4 PARK SQUARE, MILTON PARK, ABINGDO
投票 SCIE期刊PHARMACOLOGICAL RESEARCH 2024/2025影响因子:9.121 (PHARMACOL RES) (1043-6618). (PHARMACOLOGY & PHARMACY)(药理学与药学)Scienc  ...234
Total Citations:31056; 2023 JIF:9.121; JIFRank: 13/354 ; Rank-JIF: 13; Number-of-JIF:354; 5 Year JIF:9.133; 5 Year JIF Quartile:Q1; JIF Without Self Cites:8.9; Immediacy Index:1.7; Immediacy Index-dealt:1.736; 2023 JCI:2.12; JCI Rank: 11/354 ; Total Articles:293; JCI Quartile:Q1; JCI Percentile:97.03; Eigenfactor:0.033; Normalized Eigenfactor:7.155; Article Influence Score:1.703; JIF Percentile:96.5; JIF Quartile:Q1; AIS Quartile:Q1; Citable Items:329; % of Articles in Citable items:0.8906; Cited Half-Life:4; Citing Half-Life:6.3; % of OA Gold:0.4033; Publisher name:MICROBIOLOGY SOC; Publisher address:14-16 MEREDITH ST, LONDON, England, EC1R
投票 SCIE期刊PSYCHOPHARMACOLOGY 2024/2025影响因子:3.521 (PSYCHOPHARMACOLOGY) (0033-3158). (PHARMACOLOGY & PHARMACY)(药理学与药学)Science  ...234
Total Citations:20270; 2023 JIF:3.521; JIFRank: 100/354 ; Rank-JIF: 100; Number-of-JIF:354; 5 Year JIF:3.657; 5 Year JIF Quartile:Q2; JIF Without Self Cites:3.4; Immediacy Index:0.7; Immediacy Index-dealt:0.732; 2023 JCI:0.92; JCI Rank: 97/354 ; Total Articles:183; JCI Quartile:Q2; JCI Percentile:72.74; Eigenfactor:0.013; Normalized Eigenfactor:2.876; Article Influence Score:1.09; JIF Percentile:71.9; JIF Quartile:Q2; AIS Quartile:Q1; Citable Items:201; % of Articles in Citable items:0.9104; Cited Half-Life:11.9; Citing Half-Life:9.7; % of OA Gold:0.2969; Publisher name:MOSBY-ELSEVIER; Publisher address:360 PARK AVENUE SOUTH, NEW YORK, USA, N
投票 SCIE期刊Frontiers in Pharmacology 2024/2025影响因子:4.416 (FRONT PHARMACOL) (NULL). (PHARMACOLOGY & PHARMACY)(药理学与药学)Science  ...234
Total Citations:87144; 2023 JIF:4.416; JIFRank: 65/354 ; Rank-JIF: 65; Number-of-JIF:354; 5 Year JIF:5.164; 5 Year JIF Quartile:Q1; JIF Without Self Cites:4.2; Immediacy Index:0.9; Immediacy Index-dealt:0.924; 2023 JCI:1.15; JCI Rank: 61/354 ; Total Articles:2063; JCI Quartile:Q1; JCI Percentile:82.91; Eigenfactor:0.115; Normalized Eigenfactor:25.22; Article Influence Score:0.961; JIF Percentile:81.8; JIF Quartile:Q1; AIS Quartile:Q1; Citable Items:2944; % of Articles in Citable items:0.7007; Cited Half-Life:3; Citing Half-Life:5.9; % of OA Gold:0.9961; Publisher name:ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD; Publisher address:2-4 PARK SQUARE
投票 SCIE期刊JOURNAL OF CARDIOVASCULAR PHARMACOLOGY 2024/2025影响因子:2.673 (J CARDIOVASC PHARM) (0160-2446). (PHARMACOLOGY & PHAR  ...234
Total Citations:5765; 2023 JIF:2.673; JIFRank: 173/354 ; Rank-JIF: 173; Number-of-JIF:354; 5 Year JIF:2.585; 5 Year JIF Quartile:Q3; JIF Without Self Cites:2.5; Immediacy Index:0.7; Immediacy Index-dealt:0.727; 2023 JCI:0.68; JCI Rank: 168/354 ; Total Articles:70; JCI Quartile:Q2; JCI Percentile:52.68; Eigenfactor:0.003; Normalized Eigenfactor:0.675; Article Influence Score:0.517; JIF Percentile:51.3; JIF Quartile:Q2; AIS Quartile:Q3; Citable Items:93; % of Articles in Citable items:0.7527; Cited Half-Life:10.2; Citing Half-Life:6.3; % of OA Gold:0.1435; Publisher name:BRILL; Publisher address:PLANTIJNSTRAAT 2, P O BOX 9000, LEIDEN, NETHERLAN
投票 SCIE期刊Journal of Clinical Lipidology 2024/2025影响因子:3.643 (J CLIN LIPIDOL) (1933-2874). (PHARMACOLOGY & PHARMACY)(药理学与药学  ...234
Total Citations:3960; 2023 JIF:3.643; JIFRank: 94/354 ; Rank-JIF: 94; Number-of-JIF:354; 5 Year JIF:3.837; 5 Year JIF Quartile:Q2; JIF Without Self Cites:3.3; Immediacy Index:1.3; Immediacy Index-dealt:1.341; 2023 JCI:1.12; JCI Rank: 66/354 ; Total Articles:77; JCI Quartile:Q1; JCI Percentile:81.5; Eigenfactor:0.005; Normalized Eigenfactor:1.138; Article Influence Score:1.242; JIF Percentile:73.6; JIF Quartile:Q2; AIS Quartile:Q1; Citable Items:83; % of Articles in Citable items:0.9277; Cited Half-Life:5.9; Citing Half-Life:6.8; % of OA Gold:0.2539; Publisher name:PARIS SCHOLAR PUBLISHING LTD; Publisher address:1508 S GARFIELD AVE, ALHAMBRA,
投票 SCIE期刊Journal of Pharmaceutical Analysis 2024/2025影响因子:6.177 (J PHARM ANAL) (2095-1779). (PHARMACOLOGY & PHARMACY)(药理学与  ...234
Total Citations:4263; 2023 JIF:6.177; JIFRank: 26/354 ; Rank-JIF: 26; Number-of-JIF:354; 5 Year JIF:6.873; 5 Year JIF Quartile:Q1; JIF Without Self Cites:5.9; Immediacy Index:2; Immediacy Index-dealt:2.109; 2023 JCI:2.16; JCI Rank: 8/354 ; Total Articles:81; JCI Quartile:Q1; JCI Percentile:97.88; Eigenfactor:0.003; Normalized Eigenfactor:0.725; Article Influence Score:1.131; JIF Percentile:92.8; JIF Quartile:Q1; AIS Quartile:Q1; Citable Items:113; % of Articles in Citable items:0.7168; Cited Half-Life:4.4; Citing Half-Life:5.5; % of OA Gold:0.9729; Publisher name:INDERSCIENCE ENTERPRISES LTD; Publisher address:WORLD TRADE CENTER BLDG, 29 ROUT
投票 SCIE期刊COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING 2024/2025影响因子:1.631 (COMB CHEM HIGH T SCR) (1386-2073). (PHAR  ...234
Total Citations:2220; 2023 JIF:1.631; JIFRank: 259/354 ; Rank-JIF: 259; Number-of-JIF:354; 5 Year JIF:1.501; 5 Year JIF Quartile:Q4; JIF Without Self Cites:1.6; Immediacy Index:0.7; Immediacy Index-dealt:0.721; 2023 JCI:0.5; JCI Rank: 236/354 ; Total Articles:187; JCI Quartile:Q2; JCI Percentile:54.73; Eigenfactor:0.001; Normalized Eigenfactor:0.254; Article Influence Score:0.22; JIF Percentile:35.8; JIF Quartile:Q3; AIS Quartile:Q3; Citable Items:233; % of Articles in Citable items:0.8026; Cited Half-Life:5.7; Citing Half-Life:7.2; % of OA Gold:0.0362; Publisher name:BMJ PUBLISHING GROUP; Publisher address:BRITISH MED ASSOC HOUSE, TAVISTOCK
投票 SCIE期刊Asian Journal of Pharmaceutical Sciences 2024/2025影响因子:10.742 (ASIAN J PHARM SCI) (1818-0876). (PHARMACOLOGY & PH  ...234
Total Citations:4319; 2023 JIF:10.742; JIFRank: 11/354 ; Rank-JIF: 11; Number-of-JIF:354; 5 Year JIF:9.153; 5 Year JIF Quartile:Q1; JIF Without Self Cites:10.2; Immediacy Index:2.6; Immediacy Index-dealt:2.641; 2023 JCI:2.14; JCI Rank: 9/354 ; Total Articles:41; JCI Quartile:Q1; JCI Percentile:97.6; Eigenfactor:0.003; Normalized Eigenfactor:0.68; Article Influence Score:1.248; JIF Percentile:97; JIF Quartile:Q1; AIS Quartile:Q1; Citable Items:58; % of Articles in Citable items:0.7069; Cited Half-Life:4.4; Citing Half-Life:4.5; % of OA Gold:0.9551; Publisher name:LIPPINCOTT WILLIAMS & WILKINS; Publisher address:TWO COMMERCE SQ, 2001 MARKET ST,
投票 SCIE期刊BMC Pharmacology & Toxicology 2024/2025影响因子:2.815 (BMC PHARMACOL TOXICO) (NULL). (PHARMACOLOGY & PHARMACY)(药理学与药学  ...234
Total Citations:1948; 2023 JIF:2.815; JIFRank: 158/354 ; Rank-JIF: 158; Number-of-JIF:354; 5 Year JIF:2.875; 5 Year JIF Quartile:Q2; JIF Without Self Cites:2.8; Immediacy Index:0.4; Immediacy Index-dealt:0.457; 2023 JCI:0.79; JCI Rank: 130/354 ; Total Articles:64; JCI Quartile:Q2; JCI Percentile:64.62; Eigenfactor:0.002; Normalized Eigenfactor:0.456; Article Influence Score:0.59; JIF Percentile:51.4; JIF Quartile:Q2; AIS Quartile:Q3; Citable Items:73; % of Articles in Citable items:0.8767; Cited Half-Life:5; Citing Half-Life:7.5; % of OA Gold:0.9958; Publisher name:ELSEVIER SINGAPORE PTE LTD; Publisher address:3 KILLINEY ROAD 08-01, WINSLAND
投票 SCIE期刊Revista Espanola de Quimioterapia 2024/2025影响因子:1.993 (REV ESP QUIM) (0214-3429). (PHARMACOLOGY & PHARMACY)(药理学与药  ...234
Total Citations:1036; 2023 JIF:1.993; JIFRank: 231/354 ; Rank-JIF: 231; Number-of-JIF:354; 5 Year JIF:1.805; 5 Year JIF Quartile:Q3; JIF Without Self Cites:1.7; Immediacy Index:0.7; Immediacy Index-dealt:0.787; 2023 JCI:0.44; JCI Rank: 257/354 ; Total Articles:53; JCI Quartile:Q3; JCI Percentile:27.54; Eigenfactor:0.001; Normalized Eigenfactor:0.281; Article Influence Score:0.394; JIF Percentile:34.9; JIF Quartile:Q3; AIS Quartile:Q3; Citable Items:70; % of Articles in Citable items:0.7571; Cited Half-Life:4.2; Citing Half-Life:4; % of OA Gold:0.9851; Publisher name:LIPPINCOTT WILLIAMS & WILKINS; Publisher address:TWO COMMERCE SQ, 2001 MARKET
投票 SCIE期刊Dose-Response 2024/2025影响因子:2.355 (DOSE-RESPONSE) (1559-3258). (PHARMACOLOGY & PHARMACY)(药理学与药学)Science Citation  ...234
Total Citations:2350; 2023 JIF:2.355; JIFRank: 199/354 ; Rank-JIF: 199; Number-of-JIF:354; 5 Year JIF:2.563; 5 Year JIF Quartile:Q3; JIF Without Self Cites:2.2; Immediacy Index:0.7; Immediacy Index-dealt:0.755; 2023 JCI:0.62; JCI Rank: 192/354 ; Total Articles:49; JCI Quartile:Q2; JCI Percentile:51.23; Eigenfactor:0.002; Normalized Eigenfactor:0.487; Article Influence Score:0.454; JIF Percentile:58.6; JIF Quartile:Q2; AIS Quartile:Q3; Citable Items:52; % of Articles in Citable items:0.9423; Cited Half-Life:4.7; Citing Half-Life:8.9; % of OA Gold:0.8938; Publisher name:UJ MANDATUM KONYVKIADO; Publisher address:FRATER GYORGY TER 11, BUDAPEST, H
投票 SCIE期刊DRUGS & AGING 2024/2025影响因子:3.446 (DRUG AGING) (1170-229X). (PHARMACOLOGY & PHARMACY)(药理学与药学)Science Citation Ind  ...234
Total Citations:4343; 2023 JIF:3.446; JIFRank: 105/354 ; Rank-JIF: 105; Number-of-JIF:354; 5 Year JIF:3.558; 5 Year JIF Quartile:Q2; JIF Without Self Cites:3.2; Immediacy Index:0.5; Immediacy Index-dealt:0.546; 2023 JCI:0.74; JCI Rank: 149/354 ; Total Articles:58; JCI Quartile:Q2; JCI Percentile:58.05; Eigenfactor:0.003; Normalized Eigenfactor:0.759; Article Influence Score:0.95; JIF Percentile:70.5; JIF Quartile:Q2; AIS Quartile:Q1; Citable Items:90; % of Articles in Citable items:0.6444; Cited Half-Life:8.7; Citing Half-Life:7; % of OA Gold:0.3361; Publisher name:JOHNS HOPKINS UNIV PRESS; Publisher address:JOURNALS PUBLISHING DIVISION, 2715
下一页 »
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-1 13:51
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
返回顶部 返回版块